Aptorum Group company info

What does Aptorum Group do?
Aptorum Group (NASDAQ:APM) is a dynamic biopharmaceutical company dedicated to developing and commercializing a diverse range of innovative therapeutic and diagnostic technologies targeting unmet medical needs. With a strategic focus on infectious diseases and oncology, among other fields, Aptorum is actively engaged in advancing its pipeline through rigorous research and development efforts. They are committed to leveraging cutting-edge science and technology to provide new solutions that can significantly improve patient outcomes and quality of life. Their objective is to lead the way in discovering and developing novel therapeutics and diagnostics that address the critical challenges faced by patients around the globe.
Aptorum Group  company media
Company Snapshot

Is Aptorum Group a public or private company?

key
Ownership
Public

How many people does Aptorum Group employ?

people
Employees
15

What sector is Aptorum Group in?

pie chart
Sector
Health Care

Where is the head office for Aptorum Group ?

location pin
Head Office
London, England

What year was Aptorum Group founded?

founded flag
Year Founded
2010
What does Aptorum Group specialise in?
/Pharmaceutical Development /Therapeutic Programs /Drug Discovery /Bioinformatics Research /Preclinical Studies /Non-Pharmaceutical Projects

What are the products and/or services of Aptorum Group ?

Overview of Aptorum Group offerings
Smart Pharma - Utilizes artificial intelligence for drug discovery and development processes.
SACT-1 - A repurposed drug aimed at treating neuroblastoma.
ALS-4 - An antimicrobial for Staphylococcus aureus infections, including MRSA.

Who is in the executive team of Aptorum Group ?

Aptorum Group leadership team
  • Mr. Chung Yuen  Huen
    Mr. Chung Yuen Huen
    Founder, CEO & Non-Executive Director
  • Mr. Martin  Siu
    Mr. Martin Siu
    Head of Finance